E-LIB Suche - Ergebnisse für: Arya, Niki

1

Long‐term (52‐week) efficacy and safety of dapagliflozin as..:

Araki, Eiichi ; Mathieu, Chantal ; Shiraiwa, Toshihiko...
Diabetes, Obesity and Metabolism. 23 (2021) 7 - p. 1496-1504 , 2021

Link: https://doi.org/10.1111/..

2

Long‐term efficacy and safety of dapagliflozin in patients ..:

Phillip, Moshe ; Mathieu, Chantal ; Lind, Marcus...
Diabetes, Obesity and Metabolism. 23 (2020) 2 - p. 549-560 , 2020

Link: https://doi.org/10.1111/..

3

Long‐term efficacy and safety of dapagliflozin in patients ..:

Mathieu, Chantal ; Rudofsky, Gottfried ; Phillip, Moshe...
Diabetes, Obesity and Metabolism. 22 (2020) 9 - p. 1516-1526 , 2020

Link: https://doi.org/10.1111/..

4

No clinically significant pharmacokinetic interactions betw..:

Ross, Lisa L. ; Song, Ivy H. ; Arya, Niki...
BMC Infectious Diseases. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

5

Utility of concentration-effect modeling and simulation in ..:

Barbour, April M. ; Magee, Mindy ; Shaddinger, Bonnie...
The Journal of Clinical Pharmacology. 55 (2015) 6 - p. 661-670 , 2015

Link: https://doi.org/10.1002/..

6

Pharmacokinetics of dolutegravir when administered with min..:

Song, Ivy ; Borland, Julie ; Arya, Niki..
The Journal of Clinical Pharmacology. 55 (2014) 5 - p. 490-496 , 2014

Link: https://doi.org/10.1002/..

7

Bioequivalence study with lapatinib powder for oral suspens..:

Koch, Kevin M. ; Ferron‐Brady, Geraldine ; Lemmon, Colleen...
Clinical Pharmacology in Drug Development. 4 (2014) 3 - p. 203-209 , 2014

Link: https://doi.org/10.1002/..

8

Long‐term (52‐week) efficacy and safety of dapagliflozin as..:

Araki, Eiichi ; Mathieu, Chantal ; Shiraiwa, Toshihiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251623/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment ..:

Scholtes, Rosalie A ; Muskiet, Marcel H. A ; van Baar, Michiel J. B...
https://research.rug.nl/en/publications/6d7a219c-123e-497e-bcbf-86cb80998016. , 2021

Link: https://hdl.handle.net/1..

10

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment ..:

Scholtes, Rosalie A ; Muskiet, Marcel H.A ; van Baar, Michiel J.B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818331/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Long‐term efficacy and safety of dapagliflozin in patients ..:

Phillip, Moshe ; Mathieu, Chantal ; Lind, Marcus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839492/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Lower risk of heart failure and death in patients initiated..:

Kosiborod, Mikhail ; Cavender, Matthew A ; Fu, Alex Z...
Kosiborod , M , Cavender , M A , Fu , A Z , Wilding , J P , Khunti , K , Holl , R W , Norhammar , A , Birkeland , K I , Jørgensen , M E , Thuresson , M , Arya , N , Bodegård , J , Hammar , N & Fenici , P 2017 , ' Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs : The CVD-REAL study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) ' , Circulation , vol. 136 , no. 3 , pp. 249-259 . https://doi.org/10.1161/CIRCULATIONAHA.117.029190. , 2017

Link: https://portal.findresea..

13

Lower Risk of Heart Failure and Death in Patients Initiated..:

Kosiborod, Mikhail ; Cavender, Matthew A ; Fu, Alex Z...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515629/. , 2017

Link: http://www.ncbi.nlm.nih...

14

No clinically significant pharmacokinetic interactions betw..:

Ross, Lisa ; Song, Ivy ; Arya, Niki...
http://www.biomedcentral.com/1471-2334/16/347. , 2016

Link: http://www.biomedcentral..

15

Pharmacokinetics of Dolutegravir When Administered With Min..:

Song, Ivy ; Borland, Julie ; Arya, Niki..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407950/. , 2015

Link: http://www.ncbi.nlm.nih...